These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 2129719
1. [Lesion of the gastroduodenal mucosa caused by non-steroidal anti-inflammatory drugs (NSAID)]. Pastor García E. Aten Primaria; 1990 Jun; 7(6):448, 450-1. PubMed ID: 2129719 [No Abstract] [Full Text] [Related]
2. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial]. Ehrmann J, Procházka V, Konecný M, Spacek M, Urbánek K. Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422 [No Abstract] [Full Text] [Related]
3. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Wallace JL. Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035 [Abstract] [Full Text] [Related]
4. [Gastroduodenal tolerance and clinical effectiveness of therapy with lonazolac-calcium in rheumatic diseases]. Kullich W, Fromme K, Klein G. Wien Med Wochenschr; 1996 Oct; 146(17):459-64. PubMed ID: 9045528 [Abstract] [Full Text] [Related]
5. Effect of a new non-steroidal anti-inflammatory combination of a histamine H2 antagonist and indomethacin on gastroduodenal mucosal membrane in rat. Segawa Y, Omata T, Abe T, Tsuzuike N, Itokazu Y, Yoshida K, Ueda I. Arzneimittelforschung; 1992 Oct; 42(10):1232-5. PubMed ID: 1361736 [Abstract] [Full Text] [Related]
6. Treatment and prevention of NSAID induced gastroduodenal mucosal damage. Agrawal NM, Saggioro A. J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754 [Abstract] [Full Text] [Related]
7. Effects of nonsteroidal anti-inflammatory drugs and misoprostol on gastroduodenal epithelial proliferation in arthritis. Levi S, Goodlad RA, Lee CY, Walport MJ, Wright NA, Hodgson HJ. Gastroenterology; 1992 May; 102(5):1605-11. PubMed ID: 1568570 [Abstract] [Full Text] [Related]
8. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen. Lanza FL, Codispoti JR, Nelson EB. Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328 [Abstract] [Full Text] [Related]
9. Endoscopic aspects of gastroduodenal mucosa due to NSAIDs. Ruina M, Caselli M, Sartori S, Trevisani L, La Corte R, Trotta F, Alvisi V. Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():9-11. PubMed ID: 9032574 [Abstract] [Full Text] [Related]
10. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs. Lanza FL. Scand J Gastroenterol Suppl; 1989 Dec; 163():24-31. PubMed ID: 2683026 [Abstract] [Full Text] [Related]
11. [NSAID-induced damage to the gastrointestinal mucosa]. Rodonezhskaia EV, Kharchenko NV. Lik Sprava; 2001 Dec; (4):179-80. PubMed ID: 11692710 [Abstract] [Full Text] [Related]
12. A histological study of the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the gastric and duodenal mucosa. Moghal N, Jafarey NA. J Pak Med Assoc; 1989 Nov; 39(11):287-90. PubMed ID: 2516535 [Abstract] [Full Text] [Related]
13. [Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention]. Novotný I, Díte P, Kunovská M, Münzová H. Vnitr Lek; 2007 Oct; 53(10):1053-6. PubMed ID: 18072429 [Abstract] [Full Text] [Related]
14. Does sucralfate prevent short-term NSAID induced damage to the gastroduodenal mucosa? Gudjónsson H, Oddsson E, Thjodleifsson B. Digestion; 1994 Oct; 55(6):395-8. PubMed ID: 7705552 [Abstract] [Full Text] [Related]
18. Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury? Dajani EZ. Am J Gastroenterol; 1996 May; 91(5):835-6. PubMed ID: 8633566 [No Abstract] [Full Text] [Related]
19. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease. Rainsford KD, Stetsko PI, Sirko SP, Debski S. J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509 [Abstract] [Full Text] [Related]
20. [Changes in the serum pepsinogen level during therapy with acemtacin retard as a measure of gastroduodenal tolerance]. Kullich W, Klein G. Wien Med Wochenschr; 1991 May; 141(15):331-5. PubMed ID: 1949833 [Abstract] [Full Text] [Related] Page: [Next] [New Search]